STOCK TITAN

RadNet Expands to Southwest Florida with Acquisition of Radiology Regional

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)

RadNet (NASDAQ: RDNT) has acquired Radiology Regional from LucidHealth, adding 13 imaging centers across Southwest Florida (Naples, Cape Coral, Fort Myers, Port Charlotte, Sarasota).

The deal brings an estimated 400 employees, 44 contracted radiologists and is projected to add approximately $100 million of revenue to RadNet in 2026. Services include MRI, CT, PET/CT, mammography, ultrasound and X-ray.

RadNet said it will deploy its DeepHealth AI portfolio and operational processes to expand access, screening programs and clinical accuracy in the acquired centers.

Loading...
Loading translation...

Positive

  • Acquisition adds 13 imaging centers in Southwest Florida
  • Projected $100 million incremental revenue in 2026
  • Adds ~400 employees and 44 contracted radiologists
  • Planned deployment of DeepHealth AI across acquired sites

Negative

  • None.

News Market Reaction – RDNT

+0.06%
1 alert
+0.06% News Effect

On the day this news was published, RDNT gained 0.06%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Added revenue: $100 million Current price: $77.36 Q3 2025 service revenue: $522.9 million +5 more
8 metrics
Added revenue $100 million Projected 2026 revenue contribution from Radiology Regional acquisition
Current price $77.36 Pre-news trading level vs 52-week high $85.84 and low $45.0006
Q3 2025 service revenue $522.9 million Quarterly total service revenue, up from $461.1 million year-over-year
Q3 2025 diluted EPS $0.07 Diluted EPS vs $0.04 a year ago
YTD 2025 revenue $1.49 billion Year-to-date revenue reported in Q3 2025 10-Q
YTD 2025 net loss $(18.1) million Net loss to common shareholders year-to-date 2025
Quarter-end cash $804.7 million Cash balance as of Q3 2025 quarter end
Long-term notes payable $1.07 billion Long-term debt reported in Q3 2025 10-Q

Market Reality Check

Price: $72.09 Vol: Volume 949,287 is at 0.92...
normal vol
$72.09 Last Close
Volume Volume 949,287 is at 0.92x the 20-day average of 1,030,105 normal
Technical Price $77.36 is trading above the 200-day MA $65.38, reflecting a sustained uptrend pre-news

Peers on Argus

While RDNT was up 4.3% pre-announcement, key diagnostics peers also showed gains...

While RDNT was up 4.3% pre-announcement, key diagnostics peers also showed gains: GH +10.21%, CRL +3.72%, RVTY +3.7%, WGS +3.93%, SHC +2.35%, but momentum scanners did not flag a coordinated sector move.

Historical Context

5 past events · Latest: Dec 01 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Dec 01 AI product launch Positive -3.4% Launch of DeepHealth Breast Suite AI platform for breast cancer screening.
Nov 20 AI customer win Positive -1.3% Wichita Radiological Group adopts DeepHealth Operations Suite under five-year deal.
Nov 17 Clinical AI study Positive +2.8% Nature Health publication of large AI breast screening study with improved detection.
Nov 12 Strategic partnership Positive -1.3% Expanded GE HealthCare collaboration to broaden AI-powered imaging across modalities.
Nov 11 AI acquisition Positive -2.9% Acquisition of CIMAR UK to expand DeepHealth’s cloud image management footprint.
Pattern Detected

Recent AI and acquisition news skew positive in tone but often saw negative 24h price reactions, suggesting a tendency toward sell-the-news behavior.

Recent Company History

Over the last few months, RadNet focused on AI-enabled imaging and strategic acquisitions. Events included DeepHealth’s Breast Suite launch and a large real‑world AI screening study, plus collaborations with GE HealthCare and acquisitions such as CIMAR UK. Price reactions to these largely positive updates were mixed, with several negative moves despite favorable clinical and strategic implications. Today’s Southwest Florida acquisition, projected to add $100 million of 2026 revenue and 13 centers, continues the expansion theme by adding scale alongside earlier UK and remote‑scanning deals.

Market Pulse Summary

This announcement adds 13 multi-modality imaging centers in Southwest Florida, contributing an estim...
Analysis

This announcement adds 13 multi-modality imaging centers in Southwest Florida, contributing an estimated $100 million of 2026 revenue plus ~400 employees and 44 contracted radiologists. It continues RadNet’s strategy of pairing AI-driven solutions with physical network expansion, following prior acquisitions and AI launches. Investors may monitor how these centers integrate with DeepHealth tools, the impact on margins given existing $1.07 billion in long-term notes payable, and future filings that detail acquisition terms and performance.

Key Terms

mri, pet/ct, mammography, ultrasound
4 terms
mri medical
"offering that includes MRI, CT, PET/CT, mammography, ultrasound, X-ray and"
Magnetic resonance imaging (MRI) is a medical scan that uses magnetic fields and radio waves to create detailed pictures of the inside of the body, like a high-resolution camera for tissues and organs. Investors care because MRI drives demand for imaging machines, hospital services, diagnostics and can be central to clinical trial results and regulatory decisions—changes in MRI use or technology can affect revenue, capital spending and reimbursement in healthcare and medical device markets.
pet/ct medical
"offering that includes MRI, CT, PET/CT, mammography, ultrasound, X-ray and"
A PET/CT is a combined medical imaging test that overlays two scans—PET, which shows metabolic activity like a heat map of how tissues use energy, and CT, which shows detailed body structure like a map of roads and buildings. Investors care because PET/CT scans are widely used to diagnose and monitor diseases, guide treatment decisions, and support clinical trials, affecting demand for imaging equipment, hospital services, and diagnostic-related revenue streams.
mammography medical
"includes MRI, CT, PET/CT, mammography, ultrasound, X-ray and other related"
A mammography is an X‑ray examination of breast tissue used to detect tumors, calcifications or other changes before symptoms appear. For investors, mammography matters because changes in screening technology, regulatory approvals, insurance coverage or public health guidelines directly influence demand for imaging equipment, diagnostic services and related supplies — much like how a new smartphone design can shift sales for phone makers and component suppliers.
ultrasound medical
"PET/CT, mammography, ultrasound, X-ray and other related procedures."
Ultrasound uses high-frequency sound waves—like sonar or a bat’s echo—to create images or deliver targeted therapy inside the body without cutting skin. Investors care because ultrasound devices and related services drive sales across hospitals, clinics and outpatient centers, often involve recurring consumables and software upgrades, and are sensitive to technology advances, regulatory approval and reimbursement policies that affect a supplier’s revenue and growth.

AI-generated analysis. Not financial advice.

Purchase of 13 imaging centers brings cutting-edge diagnostic technology to one of Florida’s fastest-growing regions.

LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired Radiology Regional, a division of LucidHealth serving Southwest Florida. The expansion brings RadNet’s proven operational efficiencies and leading imaging technologies to 13 locations across Naples, Cape Coral, Fort Myers, Port Charlotte and Sarasota.

In the past half-century, Radiology Regional has provided a comprehensive multi-modality offering that includes MRI, CT, PET/CT, mammography, ultrasound, X-ray and other related procedures. Radiology Regional’s 13 locations add to five existing RadNet Florida imaging centers and contribute an estimated 400 additional employees and 44 contracted radiologists.

“RadNet is proud to enter a dynamic region of Florida and build on Radiology Regional’s well-trusted history,” said Steve Forthuber, President and CEO of Eastern Operations for RadNet. “As Florida’s population grows and ages, demand for advanced imaging services is accelerating. Through our clinical excellence, operations expertise and AI-powered digital health solutions, RadNet intends to bring accessible and affordable leading-edge patient care, population health screening programs and a focus on early detection of disease to the communities of Southwest Florida. Among other things, we are excited to introduce and deploy within the acquired centers the comprehensive portfolio of our DeepHealth AI-powered innovations designed to increase clinical accuracy, streamline imaging processes and improve the patient experience.”

Steve Corbeil, CEO of LucidHealth, said: “After careful consideration of the long-term success of LucidHealth and Radiology Regional, we are confident that RadNet’s acquisition creates meaningful growth opportunities for both organizations. Together, we remain steadfast in our commitment to physician-led clinical operations and delivering exceptional patient care. At LucidHealth, our strength lies in supporting a broad network of radiologists and healthcare partners. This transition enables us to sharpen our strategic focus while positioning Radiology Regional for continued success in outpatient imaging services.”

Dr. Darius Biskup, Practice President at Radiology Regional, said joining RadNet “allows us to accelerate our mission – providing Southwest Florida with the highest quality diagnostic imaging services – by gaining access to clinically validated AI technologies and operational resources that will directly benefit our patients, our radiologists and our entire care team.”

The acquisition is projected to add approximately $100 million of revenue to RadNet in 2026.

About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 407 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at radnet.com

About Radiology Regional
Radiology Regional is one of the largest physician-driven diagnostic imaging providers in the Southeast United States. With 13 imaging centers in Lee, Collier, Charlotte and Sarasota counties spanning over 115 miles of the Gulf Coast, Radiology Regional offers a full spectrum of state-of-the-art diagnostic and screening services. For over 50 years, our dedicated team has been committed to providing our patients with exceptional quality, service and the highest standard of patient care utilizing the most innovative technology available.  Learn more at RadiologyRegional.com and connect with us @RadiologyRegionalCenter.

About LucidHealth
LucidHealth powers a partnership-driven, physician-led network of community-based radiology practices serving more than 140 healthcare facilities across Ohio, West Virginia, Wisconsin, Illinois, Iowa and Connecticut. Recognized as a national leader in radiology services, LucidHealth is committed to advancing healthcare by empowering radiologists to drive innovation and deliver exceptional clinical outcomes for our patients. With more than 300 onsite and remote-based radiologists across the United States, LucidHealth provides physicians with the time, resources and support needed to focus on what matters most – caring for patients. Learn more at LucidHealth.com and connect with us @LHRadiology.

Forward Looking Statements
This communication contains certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by words such as: “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “outlook,” “plan,” “potential,” “possible,” “predict,” “project,” “seek, “should,” “target,” “will” or “would,” the negative of these words, and similar references to future periods. Examples of forward-looking statements include statements regarding the anticipated benefits of the acquisition, the impact of the acquisition on RadNet’s business and future financial and operating results and prospects, and the amount and timing of synergies from the acquisition are based on the current estimates, assumptions and projections of RadNet, and are qualified by the inherent risks and uncertainties surrounding future expectations generally, all of which are subject to change. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties, many of which are beyond RadNet’s control.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations and assumptions regarding the future of RadNet’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of RadNet’s control. RadNet’s actual results and financial condition may differ materially from those indicated in the forward-looking statements as a result of various factors. None of RadNet’s or Radiology Regional’s respective directors, executive officers or advisors provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur, or if any of them do occur, what impact they will have on the business, results of operations or financial condition of RadNet. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on RadNet’s business and the ability to realize the expected benefits of the acquisition. Risks and uncertainties that could cause results to differ from expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the acquisition, which may be affected by, among other things, the ability of RadNet or Radiology Regional to maintain relationships with its vendors, customers and providers and retain its management and key employees, (2) the ability of RadNet to achieve the synergies contemplated by the acquisition or such synergies taking longer to realize than expected, (3) costs related to the acquisition, (4) the ability of RadNet to execute successfully its strategic plans, (5) the ability of RadNet to promptly and effectively integrate Radiology Regional into its business, (6) the risk of litigation related to the acquisition, (7) the diversion of management’s time and attention from ordinary course business operations to integration matters, and (8) the risk of legislative, regulatory, economic, competitive, and technological changes. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information concerning risks, uncertainties and assumptions can be found in RadNet’s filings with the Securities and Exchange Commission (the “SEC”), including the risk factors discussed in RadNet’s most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC.

Forward-looking statements included herein are made only as of the date hereof and, except as required by applicable law, RadNet does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.

Media Contacts
Jane Mazur
Senior Vice President, Corporate Communications
RadNet
+1 585-355-5978
jane.mazur@radnet.com

Mark Stolper
Executive Vice President and Chief Financial Officer
RadNet
+1 310-445-2800


FAQ

What did RadNet announce about the Radiology Regional acquisition (RDNT) on January 7, 2026?

RadNet announced it acquired Radiology Regional, adding 13 imaging centers in Southwest Florida and projected ~$100 million revenue in 2026.

How many employees and radiologists does the Radiology Regional deal add to RadNet (RDNT)?

The acquisition contributes an estimated 400 employees and 44 contracted radiologists.

Which Southwest Florida locations are included in RadNet's acquisition of Radiology Regional (RDNT)?

The 13 locations span Naples, Cape Coral, Fort Myers, Port Charlotte and Sarasota.

How will RadNet (RDNT) use AI after acquiring Radiology Regional?

RadNet plans to deploy its DeepHealth AI-powered solutions to improve clinical accuracy, streamline imaging processes and enhance patient experience.

What imaging modalities are part of the Radiology Regional centers acquired by RadNet (RDNT)?

The centers offer multi-modality services including MRI, CT, PET/CT, mammography, ultrasound and X-ray.
Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

5.42B
67.32M
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES